Company
Every investor coverage indicates participated in a round Biota Holdings raised.
Companies Biota Holdings acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
| Name | Role | Sources |
|---|---|---|
| Dr Peter Molloy | CEO (former) | @AuManufacturing |
Stories naming Biota Holdings. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Firebrick Pharma's nasal spray, in late-stage trials, may guard against coronavirus; its founder says it could be regulated as a disinfectant, and the company raised Series C funding in 2019.